Suchergebnisse - "Myeloma"

PubPharm (293)

1

Tandem autologous hematopoietic stem cell transplantation for patients with multiple myeloma : a systematic review and meta-analysis

enthalten in: Hematology (Amsterdam, Netherlands) | 2024

von Li, H. | Zheng, Y. | Gao, K. | +1

2

Circulating plasma cells as a predictive biomarker in Multiple myeloma : an updated systematic review and meta-analysis

enthalten in: Annals of medicine | 2024

von Li, Q. | Ai, L. | Zuo, L. | +7

3

Pomalidomide combined with dexamethasone for the treatment of relapsed/refractory multiple myeloma : a systematic review and meta-analysis

enthalten in: Expert review of hematology | 2024

von Luo, Y. | Li, C. | Niu, Y. | +9

4

Safety and efficacy of anti-BCMA CAR-T cell therapy in older adults with multiple myeloma : A systematic review and meta-analysis

enthalten in: Journal of geriatric oncology | 2024

von Akhtar, O. | Sheeba, B. | Azad, F. | +15

5

Exploring the efficacy and safety of anti-BCMA chimeric antigen receptor T-cell therapy for multiple myeloma : Systematic review and meta-analysis

enthalten in: CytoJournal | 2024

von Zhang, J. | Ding, X. | Ding, X.

6

Clinical efficacy and safety of combined anti-BCMA and anti-CD19 CAR-T cell therapy for relapsed/refractory multiple myeloma : a systematic review and meta-analysis

enthalten in: Frontiers in oncology | 2024

von Xu, H. | Guan, C. | Xu, P. | +4

7

Prognostic value of circulating plasma cells detected by flow cytometry in newly diagnosed multiple myeloma patients : a systematic review and meta-analysis

enthalten in: BMJ open | 2024

von Liu, X. | Wu, F. | Ye, W. | +7

8

Efficacy and safety of bispecific antibodies therapy for relapsed or refractory multiple myeloma : a systematic review and meta-analysis of prospective clinical trials

enthalten in: Frontiers in immunology | 2024

von Wang, X. | Zhao, A. | Zhu, J. | +1

9

Efficacy and safety of bispecific antibodies therapy for relapsed or refractory multiple myeloma: a systematic review and meta-analysis of prospective clinical trials

in: Frontiers in Immunology | 2024

von Xin Wang | Ailin Zhao | Jinbing Zhu | +1

10

Clinical efficacy and safety of combined anti-BCMA and anti-CD19 CAR-T cell therapy for relapsed/refractory multiple myeloma: a systematic review and meta-analysis

in: Frontiers in Oncology | 2024

von Han Xu | Han Xu | Chaoyang Guan | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[30]